21 hours ago · Qualcomm (QCOM) reported better-than-expected Q1 results and provided upbeat guidance for Q2 Ford (F) reported upbeat Q4 earnings and revenue, but gave a FY25 outlook that was softer than expectations

1 day ago · Eli Lilly (LLY) shares are about 1% higher in premarket trading after the drugmaker's adjusted profit came in above estimates, despite reporting mostly worse-than-expected fourth-quarter results.

2 days ago · Qualcomm (QCOM) notched another big beat on its Q1 bottom line, with earnings of $3.41 per share flying past the $2.93 for the Zacks consensus.

1 day ago · Eli Lilly (LLY) reported fourth quarter and full year earnings for 2024 on Thursday, with results largely beating Wall Street estimates, sending its stock slightly higher in pre-market trading.

11 hours ago · Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and pricing challenges loom. See more here.

Dec 23, 2024 · Obesity drugmaker Eli Lilly (LLY) rises after Zepbound gets FDA approval for sleep apnea treatment. Meanwhile, Honda (HMC) and Nissan (NSANY) have begun merger discussions to potentially become the world's 3rd largest automaker. And, Qualcomm (QCOM) prevails in a legal dispute over Arm Holdings (ARM).

Aug 12, 2024 · Here are today's research calls that investors need to know, as compiled by The Fly. Deutsche Bank upgraded Eli Lilly (LLY) to Buy from Hold with a price target of $1,025, up from $725. The...

Feb 16, 2023 · Qualcomm (QCOM) Rides on Solid Automotive, 5G Traction Per the Zacks analyst, Qualcomm is well-positioned to benefit from solid 5G traction and a healthy growth in the automotive business with...

INDIANAPOLIS , Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025 …

4 days ago · Thursday, February 6 Before Market Open Eli Lilly (LLY) – markets will be keen to see updates on blockbuster drugs and the growing diabetes and obesity treatment portfolio from the pharma giant. Expected EPS: $5.15 Expected Revenue: $9.8 billion After The Bell Amazon (AMZN) – Amazon’s holiday season performance and cloud computing growth via AWS will be key factors to watch in this ...